Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Organizing biological data
HLA-C∗04:01 as the genetic risk factor of COVID-19 severity in Armenian population
HLA-C*04:01 AFFECTS HLA CLASS I HETEROZYGOSITY AND PREDICTED AFFINITY TO SARS-CoV-2 PEPTIDES, AND IN COMBINATION WITH AGE AND SEX OF ARMENIAN PATIENTS CONTRIBUTES TO COVID-19 SEVERITY
Yucca gloriosa cultivar:19.1.2.2015
Yucca gloriosa 19.1.2.2015 gene expression profiling
Methylation patterns of the nasal epigenome of hospitalized SARS-CoV-2 positive patients reveal insights into molecular mechanisms of COVID-19
Queensland Dugong Faecal Microbiome
A study of the microbiome present in faeces sampled from 47 dugongs between tropical Cleveland Bay (19.2 °S, 146.9 °E) and sub-tropical Moreton Bay (27.3 oS, 153.3 oE), Queensland, Australia.
Prevalence and persistence of SARS-CoV-2 in stool in COVID-19 positive subjects in Norfolk, UK during waves 2021/2022
SARS-CoV-2 Genomic Epidemiology in Haiti during the early COVID-19 pandemic
LIBRA-seq of human SARS-CoV-2 spike-binding B cells from COVID-19 convalescent individuals
Severe acute respiratory syndrome coronavirus 2
Whole Genome sequencing of SARS-CoV-2 variants from asymptomatic COVID-19 individuals in Japan.
Anti-SARS-COV-2 monoclonal antibodies and long-term administration of antiviral targeting viral shedding for COVID-19 in patients with B-cell lymphoma treated by anti- CD20 antibody
Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the β, δ or ο variants
Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020-February 2022
Recombinant SARS-CoV-2 delta/omicron BA.5 in Norway
Recombinant SARS-CoV-2 delta/omicron BA.5 emerging in a long-term infected COVID-19 patient
SARS-CoV-2 Infection Associated Gut Dysbiosis and Immune Response to COVID-19 Vaccine in Patients with Schizophrenia
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection [CV14]
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection [CV15]
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection [HC]
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection [CV10]
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection [CV11]
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection [CV12]
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection [CV13]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on